Algorae Pharmaceuticals Ltd. engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. It operates as an artificial intelligence enabled drug discovery and development company. The company was founded by Robert Bartlett Elliot and David Collinson in 1987 and is headquartered in Mount Eden, New Zealand.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Algorae Pharmaceuticals Ltd. market cap is $14.52M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Algorae Pharmaceuticals Ltd. 52 week high is $0.0096 as of November 20, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Algorae Pharmaceuticals Ltd. 52 week low is $0.0035 as of November 20, 2026.
Algorae Pharmaceuticals Ltd. stock price today is $0.0072.
Algorae Pharmaceuticals Ltd. stock price yesterday was $0.0035.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Algorae Pharmaceuticals Ltd.'s P/E ratio is -6.51.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Algorae Pharmaceuticals Ltd. P/B ratio is 4.9041.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Algorae Pharmaceuticals Ltd. 50-day moving average is $0.0088.